TNF and Parkinson disease: Similarly, MAPLC3b concentrations were significantly elevated in PD patients (median = 1.60 pg/mL, IQR: 1.39–2.20) versus HC (median = 0.33 pg/mL, IQR: 0.30–0.37) (U = 1256, p < 0.001), as were TNFa levels (PD: median = 1.04 pg/mL, IQR: 0.46–2.24; HC: median = 0.63 pg/mL, IQR: 0.54–0.75) (U = 888.0, p = 0.014).